Publications

Clinical

  • The efficacy and safety of Nuwiq® was assessed in three pivotal multicentre, multinational studies (GENA-01, GENA-03, and GENA-08).

    • GENA-01 - efficacy of on demand treatment and surgical prophylaxis in previously treated patients (PTPs).
    • GENA-03 - efficacy and safety in previously treated children.
    • GENA-08 - efficacy and safety of prophylactic treatment in PTPs.

 

 


Details of clinical trials sponsored by Octapharma are provided at clinicaltrials.gov and clinicaltrialsregister.eu


Copyright © 2014 | Octapharma | Legal Statement | Privacy Statement
Octapharma Ltd | The Zenith Building | 26 Spring Gardens, Manchester | M2 1AB | 2015.047.C  Date of preparation: December 2015